Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A woman with severe angioedema improved significantly after treatment with rituximab.

Belatacept may be a promising treatment for alopecia areata.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Belimumab may cause hair loss in lupus patients.

Bimekizumab effectively treated a man's chronic beard hair loss.

A patient's grey hair regained color during treatment with adalimumab.

Biosimilars lower costs but don't significantly improve access.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Baricitinib improved hair loss and arthritis in a lupus patient.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Efalizumab can cause unexpected excessive hair growth.

Ixekizumab has known and some unexpected side effects.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Adalimumab improved folliculitis decalvans in most patients.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.